Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2004;2005(3):CD000189.
doi: 10.1002/14651858.CD000189.pub2.

Short-term low-dose corticosteroids vs placebo and nonsteroidal antiinflammatory drugs in rheumatoid arthritis

P C Gotzsche, H K Johansen
Meta-Analysis

Short-term low-dose corticosteroids vs placebo and nonsteroidal antiinflammatory drugs in rheumatoid arthritis

P C Gotzsche et al. Cochrane Database Syst Rev. 2004.

Abstract

Background: The effect of low dose corticosteroids, equivalent to 15 mg prednisolone daily or less, in patients with rheumatoid arthritis has been questioned. We performed a systematic review of trials which compared corticosteroids with placebo or non-steroidal, anti-inflammatory drugs.

Objectives: To determine whether short-term (i.e. as recorded within the first month of therapy), oral low-dose corticosteroids (corresponding to a maximum of 15 mg prednisolone daily) is superior to placebo and non-steroidal, anti-inflammatory drugs in patients with rheumatoid arthritis.

Search strategy: PubMed, The Cochrane Central Register of Controlled Trials (CENTRAL ), reference lists were searched until February 2004.

Selection criteria: All randomised studies comparing an oral corticosteroid (not exceeding an equivalent of 15 mg prednisolone daily) with placebo or a non-steroidal, anti-inflammatory drug were eligible if they reported clinical outcomes within one month after start of therapy. For adverse effects, long-term trials and matched cohort studies were also selected.

Data collection and analysis: Decisions on which trials to include were made independently by two observers based on the methods sections of the trials. Standardised mean difference (random effects model) was used for the statistical analyses.

Main results: Ten studies, involving 320 patients, were included. Prednisolone had a marked effect over placebo on joint tenderness (standardised mean difference 1.30, 95% confidence interval 0.78 to 1.83), pain (1.75, 0.87 to 2.64) and grip strength (0.41, 0.13 to 0.69). Measured in the original units, the differences were 12 tender joints (6 to 18) and 22 mm Hg (5 to 40) for grip strength. Prednisolone also had a greater effect than non-steroidal, anti-inflammatory drugs on joint tenderness (0.63, 0.11 to 1.16) and pain (1.25, 0.26 to 2.24), whereas the difference in grip strength was not significant (0.31, -0.02 to 0.64). Measured in the original units, the differences were 9 tender joints (5 to 12) and 12 mm Hg (-6 to 31). The risk of adverse effects, also during moderate- and long-term use, seemed acceptable.

Reviewers' conclusions: Prednisolone in low doses (not exceeding 15 mg daily) may be used intermittently in patients with rheumatoid arthritis, particularly if the disease cannot be controlled by other means. Since prednisolone is highly effective, short-term placebo controlled trials studying the clinical effect of low-dose prednisolone or other oral corticosteroids are no longer necessary.

PubMed Disclaimer

Conflict of interest statement

None.

Figures

1.1
1.1. Analysis
Comparison 1 Oral corticosteroids vs placebo, Outcome 1 Joint tenderness.
1.2
1.2. Analysis
Comparison 1 Oral corticosteroids vs placebo, Outcome 2 Pain.
1.3
1.3. Analysis
Comparison 1 Oral corticosteroids vs placebo, Outcome 3 Grip strength.
2.1
2.1. Analysis
Comparison 2 Oral corticosteroids vs NSAIDs, Outcome 1 Joint tenderness.
2.2
2.2. Analysis
Comparison 2 Oral corticosteroids vs NSAIDs, Outcome 2 Pain.
2.3
2.3. Analysis
Comparison 2 Oral corticosteroids vs NSAIDs, Outcome 3 Grip strength.
See this image and copyright information in PMC

Update of

References

References to studies included in this review

Berry 1974 {published data only}
    1. Berry H, Huskisson EC. Isotopic indices as a measure of inflammation in rheumatoid arthritis. Ann Rheum Dis 1974;33:523‐5. - PMC - PubMed
Boardman 1967 {published data only}
    1. Boardman PL, Dudley Hart F. Clinical measurement of the anti‐inflammatory effects of salicylates in rheumatoid arthritis. BMJ 1967;4:264‐8. - PMC - PubMed
Böhm 1967 {published data only}
    1. Böhm C. Zur medikamentösen Langzeittherapie der primär chronischen Polyarthritis. Med Welt 1967;35:2047‐50. - PubMed
    1. Schoger GA. Zur beurteilung der Wirkung einer Kombination von Salicylaten und Prednisolon bei rheumatischen Erkrankungen. Arzneimittel‐Forschung 1968;18:758‐60. - PubMed
Dick 1970 {published data only}
    1. Dick WC, Nuki G, Whaley K, Deodhar S, Buchanan WW. Some aspects in the quantitation of inflammation in joints of patients suffering from rheumatoid arthritis. Rheumatol Phys Med 1970;suppl 10:40‐7. - PubMed
Jasani 1968 {published data only}
    1. Jasani MK, Downie WW, Samuels BM, Buchanan WW. Ibuprofen in rheumatoid arthritis. Ann Rheum Dis 1968;27:457‐62. - PMC - PubMed
Kirwan 2004 {published data only}
    1. Kirwan JR, Hallgren R, Mielants H, Wollheim F, Bjorck E, Persson T, et al. A randomised placebo controlled 12 week trial of budesonide and prednisolone in rheumatoid arthritis. Annals of Rheumatic Diseases 2004;63(6):688‐95. - PMC - PubMed
    1. Kirwan JR, Hickey SH, Hallgren R, Mielants H, Bjorck E, Persson T, et al. The effect of therapeutic glucocorticoids on the adrenal response in a randomized controlled trial in patients with rheumatoid arthritis. Arthritis Rheum 2006;54(5):1415‐21. - PubMed
Lee 1973a {published data only}
    1. Lee P, Jasani MK, Dick WC, uchanan W. Evaluation of a functional index in rheumatoid arthritis. Scand J Rheumatol 1973;2:71‐7. - PubMed
Lee 1973b {published data only}
    1. Lee P, Anderson JA, Miller J, Webb J, Buchanan WW. Evaluation of analgesic action and efficacy of antirheumatic drugs. J Rheumatol 1976;3:283‐94. - PubMed
    1. Lee P, Webb J, Anderson J, Buchanan WW. Method for assessing therapeutic potential of anti‐inflammatory antirheumatic drugs in rheumatoid arthritis. BMJ 1973;2:685‐8. - PMC - PubMed
Lee 1974 {published data only}
    1. Lee P, Baxter A, Carson Dick W, Webb J. An assessment of grip strength measurement in rheumatoid arthritis. Scand J Rheumatol 1974;3:17‐23. - PubMed
Stenberg 1992 {published data only}
    1. Stenberg VI, Fiechtner JJ, Rice JR, Miller DR, Johnson LK. Endocrine control of inflammation: rheumatoid arthritis. Double‐blind, crossover clinical trial. Int J Clin Pharm Res 1992;12:11‐18. - PubMed
van Gestel 1995 {published and unpublished data}
    1. Gestel AM van, Laan RFJM, Haagsma CJ, Putte LBA van de, Riel PLCM van. Oral steroids as bridge therapy in rheumatoid arthritis patients starting with parenteral gold. A randomized double‐blind placebo‐controlled trial. Br J Rheumatol 1995;34:347‐51. - PubMed
    1. Laan RFJM, Riel PLCM van, Putte LBA van de, Erning LJTO van, Hof MA van't, Lemmens JAM. Low‐dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis. Ann Intern Med 1993;119:963‐8. - PubMed

References to studies excluded from this review

Badia Flores 1969 {published data only}
    1. Badia Flores J. Valoracion del GP‐40705 en la artritis reumatoide. Prensa Med Mex 1969;34,9:382‐4. - PubMed
Capell 2004 {published data only}
    1. Capell HA, Madhok R, Hunter JA, Porter D, Morrison E, Larkin J, et al. Lack of radiological and clinical benefit over two years of low dose prednisolone for rheumatoid arthritis: results of a randomised controlled trial. Annals of the Rheumatic Diseases 2004;63(7):797‐803. - PMC - PubMed
Chamberlain 1976 {published data only}
    1. Chamberlain MA, Keenan J. The effect of low doses of prednisolone compared with placebo on function and on the hypothalamic pituitary adrenal axis in patients with rheumatoid arthritis. Rheumatol Rehabil 1976;15:17‐23. - PubMed
Deodhar 1973 {published data only}
    1. Deodhar SD, Dick WC, Hodgkinson R, Buchanan WW. Measurement of clinical response to anti‐inflammatory drug therapy in rheumatoid arthritis. Quarterly J Med 1973;166:387‐401. - PubMed
Empire Rheum 1955 {published data only}
    1. Empire Rheumatism Council. Multi‐centre controlled trial comparing cortisone acetate and acetyl salicylic acid in the long‐term treatment of rheumaoid arthritis. Ann Rheum Dis 1955;14:353‐63. - PMC - PubMed
    1. Empire Rheumatism Council. Multi‐centre controlled trial comparing cortisone acetate and acetyl salicylic acid in the long‐term treatment of rheumatoid arthritis. Ann Rheum Dis 1957;16:277‐89. - PMC - PubMed
Fearnley 1966 {published data only}
    1. Fearnley ME, Masheter HC. A controlled trial of flufenamic acid therapy in rheumatoid arthritis. Ann Phys Med 1966;8:204‐7. - PubMed
    1. Fearnly ME. An investigation of possible synergism between flufenamic acid and prednisone. Ann Phys Med 1966;suppl:109‐10. - PubMed
Gum 1966 {published data only}
    1. Gum OB. A controlled study of two preparations, paramethasone, propoxyphene, and aspirin and propoxyphene and aspirin in the treatment of arthritis. Am J Med Sci 1966;251:328‐32. - PubMed
Hansen 1999 {published data only}
    1. Hansen M, Podenphant J, Florescu A, Stoltenberg M, Borch A, Kluger E, et al. A randomised trial of differentiated prednisolone treatment in active rheumatoid arthritis. Clinical benefits and skeletal side effects. Ann Rheum Dis 1999;58(11):713‐8. - PMC - PubMed
Hantzschel 1976 {published data only}
    1. Hantzschel H, Otto W, Astapenko MG, Tautenhahn B, Trofimowa TM, Fischer H, et al. [Results of different long term treatments of patients in the early stages of rheumatoid arthritis]. Z Gesamte Inn Med 1976;31:934‐7. - PubMed
Harris 1983 {published data only}
    1. Harris ED, Emkey RD, Nicols JE, Newberg A. Low dose prednisone therapy in rheumatoid arthritis: a double blind study. J Rheumatol 1983;10:713‐21. - PubMed
Jick 1965 {published data only}
    1. Jick H, Pinals RS, Ullian R, Slone D, Muench H. Dexamethasone and dexamethasone‐aspirin in the treatment of chronic rheumatoid arthritis. Lancet 1965;2:1203‐5. - PubMed
    1. Jick H, Slone D, Dinan B, Muench H. Evaluation of drug efficacy by a preference technic. N Engl J Med 1966;275:1399‐1403. - PubMed
Joint Committee 1954 {published data only}
    1. Joint Committee of the Medical Research Council and Nuffield Foundation. A comparison of cortisone and aspirin in the treatment of early cases of rheumatoid arthritis. BMJ 1954;1:1223‐7. - PMC - PubMed
    1. Joint Committee of the Medical Research Council and Nuffield Foundation. A comparison of cortisone and aspirin in the treatment of early cases of rheumatoid arthritis. BMJ 1955;2:695‐700. - PMC - PubMed
    1. Joint Committee of the Medical Research Council and Nuffield Foundation. Long‐term results in early cases of rheumatoid arthritis treated with either cortisone or aspirin. BMJ 1957;1:847‐50. - PMC - PubMed
Joint Committee 1959 {published data only}
    1. Joint Committee of the Medical Research Council and Nuffield Foundation. A comparison of prednisolone with aspirin or other analgesics in the treatment of rheumatoid arthritis. Ann Rheum Dis 1959;18:173‐88. - PMC - PubMed
    1. Joint Committee of the Medical Research Council and Nuffield Foundation. Comparison of prednisolone with aspirin or other analgesics in the treatment of rheumatoid arthritis. Ann Rheum Dis 1960;19:331‐7. - PMC - PubMed
    1. West HF. Reumatoid arthritis. The relevance of clinical knowledge to research activities. Abstracts World Med 1967;41:401‐17.
Kirwan 1995 {published data only}
    1. Haugeberg G, Strand A, Kvien TK, Kirwan JR. Reduced loss of hand bone density with prednisolone in early rheumatoid arthritis: results from a randomized placebo‐controlled trial. Archives of Internal Medicine 2005;165(11):1293‐7. - PubMed
    1. Hickling P, Jacoby RK, Kirwan JR. Joint destruction after glucocorticoids are withdrawn in early rheumatoid arthritis. Arthritis and Rheumatism Council Low Dose Glucocorticoid Study Group. Br J Rheumatol 1998;37:930‐6. - PubMed
    1. Kirwan JR and the Arthritis and Rheumatism Council Low‐dose Glucocorticoid Study Group. The effect of glucocorticoids on joint destruction in rheumatoid arthritis. N Engl J Med 1995;333:142‐6. - PubMed
Kvien 1982 {published data only}
    1. Kvien TK, Hoyeraal HM, Sandstad B. Assessment methods of disease activity in juvenile rheumatoid arthritis ‐ evaluated in a prednisolone/placebo double‐blind study. J Rheumatol 1982;9:696‐702. - PubMed
Leszczynski 2000 {published data only}
    1. Leszczynski P, Lacki J K, Mackiewicz S H. Osteoporoza posteroidowa u chorych na reumatoidalne zapalenie stawow. Przegl Lek 2000;57(2):108‐10. - PubMed
Million 1984 {published data only}
    1. Million R, Kellgren JH, Poole P, Jayson MIV. Long‐term study of management of rheumatoid arthritis. Lancet 1984;i:812‐6. - PubMed
    1. West HF. Reumatoid arthritis. The relevance of clinical knowledge to research activities. Abstracts World Med 1967;41:401‐17.
    1. Zuckner J, Uddin J, Ramsey RH. Adrenal‐pituitary relationships with porlonged low dosage steroid therapy in rheumatoid arthritis. Missouri Med 1969;66:649‐58. - PubMed
Murthy 1978 {published data only}
    1. Murthy MHV, Rhymer AR, Wright V. Indomethacin or prednisolone at night in rheumatoid arthritis?. Rheumatol Rehab 1978;17:8‐13. - PubMed
Rau 2000 {published data only}
    1. Rau R, Wassenberg S, Zeidler H. Low dose prednisolone therapy (LDPT) retards radiographically detectable destruction in early rheumatoid arthritis ‐ preliminary results of a multicenter, randomized, parallel, double blind study. Z Rheumatol 2000;59 Suppl 2:II/90‐6. - PubMed
    1. Wassenberg S, Rau R, Steinfeld P, Zeidler H. Very low‐dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years: a multicenter, double‐blind, placebo‐controlled trial. Arthritis Rheum 2005;52(11):3371‐80. - PubMed
Siegmeth 1974 {published data only}
    1. Siegmeth W, Herkner W. Erfahrungen mit einem neuen Kombinationspräparat (Realin) bei der Behandlung akuter rheumatischer Zustandsbilder. Wien Med Wochenschr 1974;124:569‐73. - PubMed
Slonim 1969 {published data only}
    1. Slonim RR, Kiem IM, Howell DS, Brown HE. Evaluation of drug responses in the patient severely afflicted with rheumatoid arthritis. J Florida Med Assoc 1969;56,5:336‐41. - PubMed
van Everdingen 2002 {published data only}
    1. Huisman AM, Siewertsz van Everdingen AA, Wenting MJ, et al. Glucocorticoid receptor up‐regulation in early rheumatoid arthritis treated with low dose prednisone or placebo. Clin Exp Rheumatol 2003;21(2):217‐20. - PubMed
    1. Everdingen AA, Jacobs JW G, Siewertsz Van Reesema DR, Bijlsma JW J. Low‐dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease‐modifying properties, and side effects: a randomized, double‐blind, placebo‐controlled clinical trial. Ann Intern Med 2002;136(1):1‐12. - PubMed
    1. Everdingen AA, Siewertsz van Reesema DR, Jacobs JW, Bijlsma JW. Low‐dose glucocorticoids in early rheumatoid arthritis: discordant effects on bone mineral density and fractures?. Clin Exp Rheumatol 2003;21(2):155‐60. - PubMed
    1. Everdingen AA, Siewertsz van Reesema DR, Jacobs JW, Bijlsma JW. The clinical effect of glucocorticoids in patients with rheumatoid arthritis may be masked by decreased use of additional therapies. Arthritis Rheum 2004;51(2):233‐8. - PubMed
Webb 1973 {published data only}
    1. Webb J, Downie WW, Dick WC, Lee P. Evaluation of digital joint circumference measurements in rheumatoid arthritis. Scand J Rheumatol 1973;2:127‐31. - PubMed
Zuckner 1969 {published data only}
    1. Zuckner J, Uddin J, Ramsey RH. Adrenal‐pituitary relationships with porlonged low dosage steroid therapy in rheumatoid arthritis. Missouri Med 1969;66:649‐58. - PubMed

Additional references

Arnett 1988
    1. Arnett FC, Edsworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The 1987 revised American Rheumatism Association criteria for classification of rheumatoid arthritis. Arthritis and Rheumatism 1988;31:315‐24. - PubMed
Caldwell 1991
    1. Caldwell JR, Furst DE. The efficacy and safety of low‐dose corticosteroids for rheumatoid arthritis. Seminars in Arthritis and Rheumatism 1991;21:1‐11. - PubMed
Criswell 1998
    1. Criswell LA, Saag KG, Sems KM, Welch V, Shea B, Wells G, Suarez‐Almazor ME. Moderate‐term, low‐dose corticosteroids for rheumatoid arthritis. Cochrane Database of Systematic Reviews 1998, Issue 3. [DOI: 10.1002/14651858.CD001158] - DOI - PMC - PubMed
Da Silva 2006
    1. Silva JA, Jacobs JW, Kirwan JR, Boers M, Saag KG, et al. Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data. Annals of the Rheumatic Diseases 2006;65(3):285‐93. - PMC - PubMed
Dickersin 1993
    1. Dickersin K, Min Y‐I. NIH clinical trials and publication bias. Online J Curr Clin Trials 1993 Apr 28;Doc No 50. - PubMed
Gøtzsche 1989a
    1. Gøtzsche PC. Methodology and overt and hidden bias in reports of 196 double‐blind trials of nonsteroidal, antiinflammatory drugs in rheumatoid arthritis. Controlled Clinical Trials 1989;10:31‐56 (erratum: 356). - PubMed
Gøtzsche 1989b
    1. Gøtzsche PC. Meta‐analysis of grip strength: most common, but superfluous variable in comparative NSAID trials. Danish Medical Bulletin 1989;36:493‐5. - PubMed
Gøtzsche 1990a
    1. Gøtzsche PC. Sensitivity of effect variables in rheumatoid arthritis: a meta‐analysis of 130 placebo controlled NSAID trials. Journal of Clinical Epidemiology 1990;43:1313‐8. - PubMed
Gøtzsche 1990b
    1. Gøtzsche PC. Bias in double‐blind trials (thesis). Danish Medical Bulletin 1990;37:329‐36. - PubMed
Gøtzsche 1994
    1. Gøtzsche PC. Steroids and peptic ulcer: an end to the controversy? (editorial). Journal of Internal Medicine 1994;236:599‐601. - PubMed
Hench 1949
    1. Hench PS, Kendall EC, Slocumb CH, Polley HF. The effect of a hormone of the adrenal cortex (17‐hydroxy‐11‐dehydrocorticosterone: compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis. Proc Staff Meet Mayo Clin 1949;24:181‐97. - PubMed
Kirwan 2007
    1. Kirwan JR, Bijlsma JWJ, Boers M, Shea B. Effects of glucocorticoids on radiological progression in rheumatoid arthritis. Cochrane Database of Systematic Reviews 2007, Issue 1. [DOI: 10.1002/14651858.CD006356] - DOI - PMC - PubMed
McDougall 1994
    1. McDougall R, Sibley J, Haga M, Russell A. Outcome in patients with rheumatoid arthritis receiving prednisone compared to matched controls. Journal of Rheumatology 1994;21:1207‐13. - PubMed
Saag 1994
    1. Saag KG, Koehnke R, Caldwell JR, Brasington R, Burmeister LF, Zimmerman B, et al. Low dose long‐term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events. American Journal of Medicine 1994;96:115‐23. - PubMed
Savulescu 1996
    1. Savulescu J, Chalmers I, Blunt J. Are research ethics committees behaving unethically? Some suggestions for improving performance and accountability. BMJ 1996;313:1390‐3. - PMC - PubMed
Schulz 1995
    1. Schulz KF, Chalmers I, Hayes RJ, Altman D. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273:408‐12. - PubMed
Stern 1997
    1. Stern JM, Simes RJ. Publication bias: evidence of delayed publication in a cohort study of clinical research projects. BMJ 1997;315:640‐5. - PMC - PubMed
Stuck 1989
    1. Stuck AE, Minder CE, Frey FJ. Risk of infectious complications in patients taking glucocorticosteroids. Reviews of Infectious Diseases 1989;11:954‐63. - PubMed
Weiss 1989
    1. Weiss MM. Corticosteroids in rheumatoid arthritis. Seminars in Arthritis and Rheumatism 1989;19:9‐21. - PubMed

References to other published versions of this review

Gøtzsche 1998
    1. Gøtzsche PC, Johansen HK. Meta‐analysis of short‐term low‐dose prednisolone vs placebo and nonsteroidal, antiinflammatory drugs in rheumatoid arthritis. BMJ 1998;316:811‐8. - PMC - PubMed
Gøtzsche 2001
    1. Gøtzsche PC, Johansen HK. Short‐term low‐dose corticosteroids vs placebo and nonsteroidal antiinflammatory drugs in rheumatoid arthritis. Cochrane Database of Systematic Reviews 2001, Issue 2. [DOI: 10.1002/14651858.CD000189.pub2] - DOI - PubMed

MeSH terms

LinkOut - more resources